title: New development of medicines for priority diseases in Africa.
authors.affiliation: Immunization and Vaccines Development Programme, Family and Reproductive Health Cluster, WHO Regional Office for Africa, Brazzaville Box 03 Djoue, Republic of the Congo. Electronic address: akanmorib@who.int.
authors.forename: Bartholomew D
authors.initials: BD
authors.lastname: Akanmori
authors.affiliation: Immunization and Vaccines Development Programme, Family and Reproductive Health Cluster, WHO Regional Office for Africa, Brazzaville Box 03 Djoue, Republic of the Congo.
authors.forename: David O
authors.initials: DO
authors.lastname: Mukanga
authors.affiliation: Immunization and Vaccines Development Programme, Family and Reproductive Health Cluster, WHO Regional Office for Africa, Brazzaville Box 03 Djoue, Republic of the Congo.
authors.forename: Richard
authors.initials: R
authors.lastname: Mihigo
authors.affiliation: Department of Essential Medicines and Health Products, Health Innovation Systems, WHO Headquarters, Geneva, Switzerland.
authors.forename: Michael
authors.initials: M
authors.lastname: Ward
authors.affiliation: Global Health Division, Bill & Melinda Gates Foundation, Seattle, WA, USA.
authors.forename: Vincent
authors.initials: V
authors.lastname: Ahonkhai
authors.affiliation: Regional Director's Office, WHO Regional Office for Africa, Brazzaville, Republic of the Congo.
authors.forename: Matshidiso R
authors.initials: MR
authors.lastname: Moeti
mesh_terms: D000349:Africa; D002986:Clinical Trials as Topic; D003140:Communicable Disease Control / Q000458:organization & administration; D003141:Communicable Diseases / Q000188:drug therapy*; D017281:Cost of Illness; D055808:Drug Discovery / Q000331:legislation & jurisprudence / Q000639:trends; D006292:Health Priorities; D006801:Humans; D014612:Vaccines; D014765:Viral Vaccines
chemical_list: D014612:Vaccines; D014765:Viral Vaccines